Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial.
Matasar M, Bartlett NL, Shadman M, Budde LE, Flinn I, Gregory GP, Kim WS, Hess G, El-Sharkawi D, Diefenbach CS, Huang H, To I, Parreira J, Wu M, Kwan A, Assouline S. Matasar M, et al. Among authors: parreira j. Clin Lymphoma Myeloma Leuk. 2024 Apr;24(4):240-253. doi: 10.1016/j.clml.2023.12.005. Epub 2023 Dec 12. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38195322 Free article. Clinical Trial.
Comparative effectiveness between mosunetuzumab monotherapy clinical trial and real-world data in relapsed/refractory follicular lymphoma in third or subsequent lines of systemic therapy.
McGough SF, Shamas N, Wang J, Jaber M, Swarup B, Blanchet Zumofen MH, Lautié B, Parreira J, Wei MC, Shewade A. McGough SF, et al. Among authors: parreira j. Leuk Lymphoma. 2023 Dec;64(14):2269-2278. doi: 10.1080/10428194.2023.2262066. Epub 2023 Dec 25. Leuk Lymphoma. 2023. PMID: 37840271
Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis.
Canales MA, Buchholz TA, Bortolini JAP, Fogliatto LM, Ishikawa T, Izutsu K, Salar A, Sharman JP, Klingbiel D, Pokala S, Vorozheikina E, Trask P, Parreira J, Hübel K. Canales MA, et al. Among authors: parreira j. Hemasphere. 2023 Mar 30;7(4):e860. doi: 10.1097/HS9.0000000000000860. eCollection 2023 Apr. Hemasphere. 2023. PMID: 37008164 Free PMC article. No abstract available.
Trauma Registry: Trauma Quality indicators analysis in hospitalized patients.
Pivetta LGA, Antunes PSL, Shimoda GM, Parreira JG, Perlingeiro JAG, Assef JC. Pivetta LGA, et al. Among authors: parreira jg. Rev Col Bras Cir. 2024 Apr 8;51:e20243604. doi: 10.1590/0100-6991e-20243604-en. eCollection 2024. Rev Col Bras Cir. 2024. PMID: 38597571 Free article. English, Portuguese.
Brazilian guidelines on diagnosis and management of traumatic vascular injuries.
Góes AMO, Parreira JG, Kleinsorge GHD, Dalio MB, Alves PHF, Gomes FJSDV, de Araujo WJB, Joviliano EE, de Oliveira JCP. Góes AMO, et al. Among authors: parreira jg. J Vasc Bras. 2023 Oct 30;22:e20230042. doi: 10.1590/1677-5449.202300422. eCollection 2023. J Vasc Bras. 2023. PMID: 38021277 Free PMC article.
90 results